z-logo
open-access-imgOpen Access
Reply to Kalil et al., “Is Daptomycin plus Ceftaroline Associated with Better Clinical Outcomes than Standard of Care Monotherapy for Staphylococcus aureus Bacteremia?”
Author(s) -
George Sakoulas,
Matthew Geriak,
Fadi Haddad,
Warren E. Rose,
Kerry L. LaPlante,
Marcus Zervos,
Ravina Kullar,
Victor Nizet
Publication year - 2019
Publication title -
antimicrobial agents and chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.07
H-Index - 259
eISSN - 1070-6283
pISSN - 0066-4804
DOI - 10.1128/aac.01347-19
Subject(s) - daptomycin , medicine , bacteremia , staphylococcus aureus , staphylococcal infections , antibiotics , intensive care medicine , microbiology and biotechnology , vancomycin , bacteria , biology , genetics

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom